Last quarter (Q4 2022), Mayne Pharma Group's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Mayne Pharma Group's net income was $―. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Total Revenue	$ ―	$ 423.92M	$ 400.32M	$ 456.60M	$ 523.96M	$ 529.14M
Cost of Revenue	$ ―	$ 253.77M	$ 205.58M	$ 231.49M	$ 222.60M	$ 266.26M
Gross Profit	$ ―	$ 170.15M	$ 194.74M	$ 225.11M	$ 301.36M	$ 262.88M
Operating Expense	$ ―	$ 171.69M	$ 173.44M	$ 226.60M	$ 278.92M	$ 225.13M
Operating Income	$ ―	$ -1.54M	$ 21.30M	$ -1.49M	$ 22.44M	$ 37.76M
Net Non Operating Interest Income Expense	$ ―	$ -31.97M	$ -32.13M	$ -30.75M	$ -16.43M	$ -17.14M
Other Income Expense	$ ―	$ -204.20M	$ -253.06M	$ -110.62M	$ -359.66M	$ -187.35M
Pretax Income	$ ―	$ -217.82M	$ -263.89M	$ -135.37M	$ -353.72M	$ -166.79M
Tax Provision	$ ―	$ 56.13M	$ -54.80M	$ -40.83M	$ -69.97M	$ -32.53M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -263.34M	$ -208.42M	$ -92.79M	$ -280.87M	$ -133.98M
Basic EPS	$ ―	$ -3.20	$ -0.13	$ -0.06	$ -0.19	$ ―
Diluted EPS	$ ―	$ -3.20	$ -0.13	$ -0.06	$ -0.19	$ ―
Basic Average Shares	$ ―	$ 82.30M	$ 1.57B	$ 1.53B	$ 1.48B	$ ―
Diluted Average Shares	$ ―	$ 82.30M	$ 1.57B	$ 1.53B	$ 1.48B	$ ―
Dividend Per Share	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -263.34M	$ -208.42M	$ -92.79M	$ -280.87M	$ -133.98M
Normalized Income	$ ―	$ -145.12M	$ -19.20M	$ -17.84M	$ 1.28M	$ 19.13M
Interest Expense	$ ―	$ 32.10M	$ 32.35M	$ 31.06M	$ 17.44M	$ 17.25M
EBIT	$ ―	$ -185.72M	$ -231.54M	$ -104.31M	$ -336.27M	$ -149.54M
EBITDA	$ ―	$ -104.64M	$ -163.35M	$ -19.75M	$ -241.78M	$ -71.83M

Currency in USD

Mayne Pharma Group Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing